Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Nivaquine P 50mg Suspension

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Chloroquine (50mg)

Overview Nivaquine P 50mg Suspension

Chloroquine phosphate 50mg oral suspension is an anti-parasitic medication used for malaria prophylaxis and treatment resulting from mosquito bites. It's also indicated for treating amoebic dysentery in children. Administer the suspension orally, ideally post-meal, to minimize stomach upset. Avoid concurrent antacid use within a four-hour window due to potential absorption interference. The suspension may taste slightly bitter; mixing with juice can improve palatability. If vomiting occurs shortly after administration, soothe your child and repeat the dose after 30 minutes; however, omit the dose if the next scheduled dose is imminent. Never double the dose. Dosage, frequency, and administration method should strictly adhere to your doctor's instructions, which are tailored to your child's weight, age, health status, and response to treatment. Initial doses may be higher for the first one or two days, followed by a lower maintenance dose. Consistent adherence to the prescribed regimen is crucial, as prolonged use can lead to adverse effects. Potential side effects include headache, nausea, anorexia, diarrhea, gastrointestinal discomfort, rash, pruritus, alopecia, and photosensitivity. These are usually transient; however, persistent symptoms warrant medical attention. Complete disclosure of your child's medical history, including allergies, current medications, and any pre-existing liver, kidney, neurological, cardiac, myopathic, genetic, hematological, or ophthalmological conditions, is vital for optimal treatment planning.

Uses of Nivaquine P 50mg Suspension

Managing Amoebic Infections and Malaria

Major Benefits of Nivaquine P 50mg Suspension:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Always consult the product label for complete instructions prior to consumption. Use a measuring device to accurately dispense the oral dose. Ensure thorough shaking before each use. Nivaquine P 50mg Suspension should be ingested with food.

Common Side effects of Nivaquine P 50mg Suspension:

  • Upset stomach
  • Photosensitivity
  • Rash
  • Headache
  • Dizziness
  • Vomiting
  • Nausea
  • Stomach pain
  • Loss of appetite
  • Diarrhea

How to use Nivaquine P 50mg Suspension:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Always consult the product label for usage instructions prior to consumption. Accurate measurement should be achieved using a measuring cup; oral administration is recommended. Ensure thorough shaking before each dose. Nivaquine P 50mg Suspension should be ingested with food.

How Nivaquine P 50mg Suspension works:

Chloroquine phosphate 50mg oral suspension combats parasitic infections, specifically malaria and amoebiasis. Its mechanism involves elevating heme concentrations and intracellular pH within infected red blood cells, disrupting parasite viability. Additionally, it directly targets the malarial parasite's DNA, resulting in parasite death and halting infection progression.

SAFETY ADVICE

KidneyKidneySAFE IF PRESCRIBED

Nivaquine P 50mg Suspension can be used safely in patients with kidney disorders; dosage modification is unnecessary. Nevertheless, extended administration could potentially affect renal function in children. Its use is contraindicated in children with severe kidney impairment.

LiverLiverCAUTION

Patients with liver conditions should exercise caution when using Nivaquine P 50mg Suspension. Dosage modification for Nivaquine P 50mg Suspension might be necessary. Physician consultation is advised.

What if you forget to take Nivaquine P 50mg Suspension :

Remain calm. If your pediatrician hasn't instructed otherwise, administer the forgotten dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose; adhere to the recommended medication schedule.

Facts to Know About Nivaquine P 50mg Suspension

LabelValue
Type of Compound 4-Aminoquinoline-based compound
Potential for Dependence None.
Type of Treatment Eye medication.
Mechanism of Action Quinoline-based antimalarials

FAQs on Nivaquine P 50mg Suspension

To diagnose malaria in your child, laboratory analysis is necessary. This may include a complete blood count, a blood smear examination, or a rapid malaria diagnostic test.
Children possessing G6PD enzyme deficiency must not use Nivaquine P 50mg Suspension. This enzyme deficiency can cause hemolysis, leading to serious anemia. Pre-treatment assessment of your child's enzyme levels is recommended.
Nivaquine P 50mg Suspension can interact with other medications or substances. Consequently, it's recommended that you disclose all other medications your child is using to your physician prior to commencing treatment with Nivaquine P 50mg Suspension.
Maintain Nivaquine P 50mg Suspension at room temperature, in a dry, cool, and dark location. Keep this medication inaccessible to children to prevent accidental ingestion.
Paludrine 50mg oral suspension is a medication employed in malaria prophylaxis and treatment.
Malaria symptoms can emerge within a week of an infected mosquito bite. More commonly, however, these symptoms manifest between seven and eighteen days post-infection. Early malaria symptoms mimic influenza, presenting as chills, fever, myalgia, nausea, cephalalgia, and diarrhea.
Prolonged use of Nivaquine P 50mg Suspension, as directed by your physician, necessitates regular eye examinations. This is a precaution due to the chloroquine content, which can potentially induce blurred vision, reading difficulties (manifesting as word loss), and, infrequently, retinopathy with extended treatment.
Consult your physician regarding any history of psoriasis prior to commencing treatment with Nivaquine P 50mg Suspension, as it could potentially exacerbate the condition.
Abdominal discomfort, queasiness, emesis, and cephalalgia are frequently reported adverse reactions to this medication. Consuming the medication with food may often mitigate these effects.
Insufficient clinical evidence supports chloroquine's efficacy against COVID-19. Consequently, using Nivaquine P 50mg Suspension for COVID-19 treatment without a physician's consultation is ill-advised.
Allow at least four hours to elapse between taking an antacid and other medications.
Both hydroxychloroquine and chloroquine initially gained approval as malaria treatments. Nevertheless, chloroquine is associated with a significantly higher incidence of adverse reactions compared to hydroxychloroquine. Consequently, hydroxychloroquine enjoys more widespread current use. Furthermore, hydroxychloroquine holds approvals for rheumatoid arthritis and lupus, therapeutic applications lacking for chloroquine.
Protect yourself from malaria by employing preventative measures such as wearing long sleeves and trousers to deter mosquito bites, using mosquito netting, and applying insect repellent. Consult your physician to determine if prophylactic antimalarial medication is necessary. If prescribed, ensure you take the correct antimalarial drug, in the correct dosage, and complete the entire course of treatment.
Nivaquine P 50mg Suspensi...
14
MRP 17
16% off